Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today, the UK Government has announced the launch of five new research hubs to develop quantum technologies in areas ranging from healthcare and computing to national security and critical infrastructure. One of the hubs will be led by the University of Oxford, and aims to develop the technologies needed for the UK to play a key role in the development of quantum computers - a market estimated to be worth $1.3 trillion by 2035.

Quantum computer © bpawesome, Getty Images

The new hubs, which are being supported by a £160 million investment, were announced today by Secretary of State for Science, Innovation and Technology, Peter Kyle. He said: 'We want to see a future where cutting-edge science improves everyday lives. That is the vision behind our investment in these new quantum technology hubs, by supporting the deployment of technology that will mean faster diagnoses for diseases, critical infrastructure safe from hostile threats, and cleaner energy for us all.'

The Hub for Quantum Computing via Integrated and Interconnected Implementations (QCI3) is led by the University of Oxford. Within the hub, researchers will work closely with industry partners to identify and develop real-world applications of quantum computing, including focusing on design for new materials, chemicals, fluid simulation techniques, and machine learning. For example, the hub will work on the development of quantum machine learning protocols which are key to the development of quantum neural networks with applications in areas such as fraud detection.

The work will involve over 50 co-investigators with expertise across many different aspects of quantum computing, based at 18 institutions throughout the UK. The Hub will also engage with around 30 industry partners, who have already pledged support through £9.9M funding.

Oxford also has a strong involvement in the other four newly-launched quantum hubs. Professor Dame Molly Stevens (Kavli Insitute for Nanoscience Discovery, Department of Engineering Science and Department of Physiology, Anatomy and Genetics, University of Oxford) will be Deputy Director of the Q-BIOMED hub led by UCL and Cambridge which aims to use quantum technologies to transform early disease diagnosis. This could include quantum-enhanced blood tests to diagnose infectious diseases and cancer quickly and cheaply using portable instruments, saving time and reducing costs to the NHS.

Professor Dame Molly Stevens said: ‘We are excited to take our ultrasensitive biosensing work to the next stage by utilising quantum technologies in the UK's first Quantum Research Hub dedicated to health. Our multidisciplinary consortium will tackle important challenges in disease diagnosis to enable better patient outcomes across a range of diseases.’

Read the full story on the University of Oxford website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience